Press Releases - 2023-11-13

Date	Title	Company
13-Nov-2023	Bloomsbury Genetic Therapies Celebrates its One Year Anniversary and Outlines Key Strategic and Operational Achievements since Launch	Bloomsbury Genetic Therapies
13-Nov-2023	OGT to premiere SureSeq™ Myeloid MRD panel at AMP	OGT, A Sysmex Group Company
13-Nov-2023	IO Biotech Announces 2023 Third Quarter Results	IO Biotech
13-Nov-2023	IO Biotech Appoints Helen Collins, MD, to its Board of Directors	IO Biotech
13-Nov-2023	Resolution Therapeutics’ founders present clinical proof-of-concept for macrophage cell therapy in end-stage liver disease at AASLD	Resolution Therapeutics Limited
13-Nov-2023	Mission Therapeutics announces publication in Nature Communications outlining potential of experimental drug MTX325 as a disease-modifying therapy for Parkinson’s Disease	Mission Therapeutics
13-Nov-2023	KFSH&RC Succeeds in Applying Advanced Gene Therapy for Patients with Hemophilia	KFSH&RC
13-Nov-2023	Oxolife Appoints International Fertility Experts to its Scientific Advisory Board	Oxolife
13-Nov-2023	Model N Management to Present at the RBC Capital Markets Global Technology, Internet, Media, Telecommunications Conference	Businesswire
13-Nov-2023	Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology	Businesswire
13-Nov-2023	Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology	Businesswire
13-Nov-2023	Kelso Pharma initiates European expansion with acquisition of Italian specialty pharma company, Velit Biopharma	Kelso Pharma
13-Nov-2023	Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3	Businesswire
13-Nov-2023	Thermo Fisher Scientific Opens Customer Experience Center for Battery Manufacturing in Seoul	Businesswire
13-Nov-2023	Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023	Businesswire
13-Nov-2023	Ankyra Therapeutics Announces Clinical Trial Supply Agreement with Regeneron to Evaluate ANK-101 in Combination with Libtayo® (cemiplimab) in Patients with Cutaneous Squamous Cell Carcinoma	Businesswire
13-Nov-2023	Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program	Businesswire
13-Nov-2023	Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next‑Generation Lithium Therapeutic Drug Candidate AL001	Businesswire
13-Nov-2023	Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update	Businesswire
13-Nov-2023	Syngenta Group Announces Mary-Dell Chilton Awarded National Medal of Technology and Innovation	Businesswire